
|Articles|June 25, 2008
Intravitreal corticosteroid approved
Trivaris (triamcinolone acetonide injectable suspension; Allergan), a synthetic glucocorticoid corticosteroid, has been approved by the FDA for the treatment of inflammatory ophthalmic conditions.
Advertisement
Trivaris (triamcinolone acetonide injectable suspension; Allergan), a synthetic glucocorticoid corticosteroid, has been approved by the FDA for the treatment of inflammatory ophthalmic conditions.
Trivaris 80 mg/mL has been indicated for sympathetic ophthalmia, temporal arteritis, uveitis and other conditions unresponsive to treatment with topical corticosteroids.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Laru-zova meets primary endpoint in pivotal VISTA trial for X-linked retinitis pigmentosa
2
How screen time and eyelid health affect dry eye risk
3
ESCRS 2026: Ultra-widefield imaging in paediatric eye care
4
ESCRS 2026: Why surgeons should be willing to use what they prescribe to patients
5












